Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

45
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
45
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

41
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
41
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

50
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
50

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes.

Diabetes care·2026
Same author

Update on antineutrophil cytoplasmic antibody vasculitis: Erratum.

Current opinion in nephrology and hypertension·2026
Same author

Heterozygous X-linked Alport syndrome in a pregnant woman: A case report.

SAGE open medical case reports·2026
Same author

Immunoglobulin A Nephropathy With Associated Thrombotic Microangiopathy: Biopsy and Clinical Case Series.

Clinical medicine insights. Case reports·2026
Same author

Update on antineutrophil cytoplasmic antibody vasculitis.

Current opinion in nephrology and hypertension·2025
Same author

Leptin and Adiponectin as Uremic Adipokines: Associations with Survival in a Prospective Hemodialysis Cohort.

Toxins·2025

相关实验视频

Updated: Sep 17, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

16.2K

血栓性微血管病变 - - 血栓性微血管病变

Ramy Hanna1, Ryan Gibney2, Megan Boysen-Osborn2

  • 1Division of Nephrology, Department of Medicine, University of California, 101 The City Drive, Orange, CA 92868, USA.

Emergency medicine clinics of North America
|July 3, 2025
PubMed
概括

血栓微血管病 (TMA) 是一种罕见的血管疾病,导致血栓形成. 早期诊断和评估对于管理这些严重疾病至关重要,包括血栓性血栓细胞缩性紫外线 (TTP),以改善患者的治疗结果.

关键词:
在 ADAMTS13 缺陷中.应急诊断和实验室检测微血管病的血液溶解性贫血症血栓性微血管病变 - - 血栓性微血管病变血栓性血栓细胞低血压性紫外线

更多相关视频

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.9K

相关实验视频

Last Updated: Sep 17, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

16.2K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.9K

科学领域:

  • 血液学 血液学 血液学
  • 内部医学 内部医学
  • 病理学 病理学 病理学

背景情况:

  • 血栓微血管病 (TMAs) 是一组罕见的,严重的疾病.
  • 它们涉及内皮损伤和微血管血栓的形成.
  • TMAs可能会导致微血管病变的血液溶解性贫血,血栓细胞减小和末端器官损伤.

研究的目的:

  • 突出TMA在紧急情况下的诊断挑战.
  • 强调早期识别和评估TMA的重要性.
  • 讨论实验室测试在诊断TMAs中的关键作用.

主要方法:

  • 对TMAs的临床表现和诊断标准的审查.
  • 分析常见的实验室检测结果,包括全血细胞计和周围涂抹.
  • 讨论特定的TMA类型,如血栓性血栓细胞性紫外线 (TTP).

主要成果:

  • TMA的特征是内皮损伤和微血管血栓形成.
  • 关键的临床特征包括溶血性贫血和血栓细胞衰减.
  • 血栓性血栓缩性紫外线 (TTP) 呈现出严重的血栓缩,血液溶解性贫血和正常的凝血因子.

结论:

  • 在急诊室诊断TMA是复杂的.
  • 及时的实验室评估对于及时诊断至关重要.
  • 早期识别和管理TMA,特别是TTP,对于降低死亡率和改善患者的治疗结果至关重要.